NeueHealth (NYSE:NEUE) Trading Down 2% – What’s Next?

NeueHealth, Inc. (NYSE:NEUE)’s stock price was down 2% on Monday . The stock traded as low as $6.75 and last traded at $6.74. Approximately 2,130 shares were traded during trading, a decline of 90% from the average daily volume of 20,434 shares. The stock had previously closed at $6.88.

NeueHealth Stock Performance

The firm has a market cap of $60.17 million, a price-to-earnings ratio of -0.13 and a beta of 0.53. The company’s fifty day moving average is $6.59 and its two-hundred day moving average is $6.47.

NeueHealth (NYSE:NEUE) last posted its earnings results on Thursday, May 8th. The company reported ($1.80) earnings per share for the quarter, beating the consensus estimate of ($2.51) by $0.71. The business had revenue of $215.79 million for the quarter, compared to analyst estimates of $249.50 million. NeueHealth had a negative net margin of 36.28% and a negative return on equity of 6.40%. As a group, analysts forecast that NeueHealth, Inc. will post -9.13 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, CEO George Lawrence Mikan III sold 26,660 shares of the business’s stock in a transaction dated Friday, March 7th. The shares were sold at an average price of $7.19, for a total value of $191,685.40. Following the completion of the sale, the chief executive officer now owns 178,756 shares of the company’s stock, valued at approximately $1,285,255.64. The trade was a 12.98% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Jay Matushak sold 4,448 shares of the business’s stock in a transaction dated Thursday, March 13th. The stock was sold at an average price of $6.74, for a total transaction of $29,979.52. Following the completion of the sale, the chief financial officer now directly owns 41,592 shares of the company’s stock, valued at $280,330.08. The trade was a 9.66% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 68,762 shares of company stock valued at $471,711 in the last quarter. Company insiders own 63.30% of the company’s stock.

Institutional Investors Weigh In On NeueHealth

Several hedge funds and other institutional investors have recently modified their holdings of NEUE. Virtu Financial LLC bought a new stake in shares of NeueHealth in the 4th quarter worth about $76,000. Northern Trust Corp increased its position in shares of NeueHealth by 66.8% in the 4th quarter. Northern Trust Corp now owns 32,644 shares of the company’s stock worth $242,000 after purchasing an additional 13,074 shares during the last quarter. Finally, PenderFund Capital Management Ltd. bought a new stake in shares of NeueHealth in the 1st quarter worth about $197,000. Institutional investors own 63.88% of the company’s stock.

NeueHealth Company Profile

NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.